Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ultralente Insulin

Known as: Insulin ultralente, Insulin, Ultralente [Chemical/Ingredient], Insulin, Ultralente 
A long-acting form of crystalline insulin often used in combination with a short-acting insulin in the treatment of diabetes mellitus. Administered… Expand
National Institutes of Health

Related topics

Related topics

9 relations

Broader (2)

Hypoglycemic AgentsInsulin
In BloodInsulin ultralente:Mass:Pt:Dose:QnProcess of secretionaspects of radiation effects
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargine.
BACKGROUND The large fluctuations in blood concentrations and activity observed with insulin therapies such as NPH insulin or… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique
Aims/hypothesisThis single-dose, double-blind, randomised, parallel-group study evaluated the reproducibility in systemic… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Strict insulin therapy normalises organ nitrogen contents and the capacity of urea nitrogen synthesis in experimental diabetes in rats
SummaryRats with experimental diabetes due to streptozotocin (75 mg/kg body weight) and free access to food were divided into two… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals
SummaryA group of 36 diabetes-prone BB Wistar rats were given prophylactic insulin treatment with heat-treated bovine ultralente… Expand
  • table 1
Is this relevant?
Review
2002
Review
2002
Novel insulins: expanding options in diabetes management.
Management of type 1 and type 2 diabetes mellitus with intensive insulin therapy usually includes an intermediate- or long-acting… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study
BACKGROUND Effective glycaemic control in type 1 diabetes mellitus usually requires two or more insulin injections daily. Inhaled… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen.
OBJECTIVE In this study, we evaluated the effects of high-(55%) and low-(40%) carbohydrate diets on insulin requirements in nine… Expand
Is this relevant?
1996
1996
Ultralente insulin treatment of transient neonatal diabetes mellitus.
In an infant with transient neonatal diabetes mellitus, control of the blood glucose concentration was attained with ultralente… Expand
Is this relevant?
Highly Cited
1986
Highly Cited
1986
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.
Two groups of adult male Munich-Wistar rats and a third group of nondiabetic age-matched and weight-matched normal control rats… Expand
  • table I
  • figure 1
  • table II
  • figure 2
  • table III
Is this relevant?
Highly Cited
1985
Highly Cited
1985
Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.
Six groups of Munich-Wistar rats underwent micropuncture study 2-10 weeks and morphologic studies 11-13 months after induction of… Expand
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE